Fengfeng Han

958 total citations
29 papers, 689 citations indexed

About

Fengfeng Han is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Fengfeng Han has authored 29 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 5 papers in Epidemiology. Recurrent topics in Fengfeng Han's work include Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Asthma and respiratory diseases (5 papers) and Respiratory Support and Mechanisms (3 papers). Fengfeng Han is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers), Asthma and respiratory diseases (5 papers) and Respiratory Support and Mechanisms (3 papers). Fengfeng Han collaborates with scholars based in China, Japan and United States. Fengfeng Han's co-authors include Xuejun Guo, Weiguo Xu, Lin Song, Xiahui Ge, Xuejun Guo, Wen Gu, Xi Chen, Zhilei Cui, Xiaojun Guan and Wenbin Guan and has published in prestigious journals such as PLoS ONE, IEEE Transactions on Geoscience and Remote Sensing and Medicine.

In The Last Decade

Fengfeng Han

28 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengfeng Han China 16 318 161 154 96 90 29 689
Jue Ye China 16 275 0.9× 238 1.5× 76 0.5× 37 0.4× 101 1.1× 31 728
Mary Van Demark United States 9 336 1.1× 329 2.0× 231 1.5× 102 1.1× 102 1.1× 13 847
Yen‐Ta Chen Taiwan 11 116 0.4× 168 1.0× 107 0.7× 81 0.8× 211 2.3× 13 662
Bo Cui China 16 135 0.4× 182 1.1× 69 0.4× 93 1.0× 65 0.7× 51 621
Martine Lelièvre-Pégorier France 25 298 0.9× 550 3.4× 100 0.6× 88 0.9× 170 1.9× 40 1.5k
Padmini P. S. J. Khedoe Netherlands 12 185 0.6× 258 1.6× 431 2.8× 56 0.6× 143 1.6× 23 1.1k
Huanping Zhou China 14 165 0.5× 356 2.2× 82 0.5× 62 0.6× 70 0.8× 24 770
Aina Noguera Spain 14 408 1.3× 145 0.9× 252 1.6× 31 0.3× 36 0.4× 20 697

Countries citing papers authored by Fengfeng Han

Since Specialization
Citations

This map shows the geographic impact of Fengfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengfeng Han more than expected).

Fields of papers citing papers by Fengfeng Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengfeng Han. The network helps show where Fengfeng Han may publish in the future.

Co-authorship network of co-authors of Fengfeng Han

This figure shows the co-authorship network connecting the top 25 collaborators of Fengfeng Han. A scholar is included among the top collaborators of Fengfeng Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengfeng Han. Fengfeng Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Wei, Yi Cheng, Mei Xu, et al.. (2025). Adjuvant effect of green tea intake on treatment of patients with acute venous thromboembolism. QJM. 118(5). 337–343.
2.
Mo, Xiaofei, et al.. (2024). Association of serum 25-hydroxy-vitamin D concentration and risk of mortality in cancer survivors in the United States. BMC Cancer. 24(1). 545–545. 4 indexed citations
3.
Rong, Zhao, et al.. (2023). A raster-based method for the hierarchical selection of river networks based on stream characteristics. International Journal of Geographical Information Systems. 37(10). 2262–2287. 1 indexed citations
4.
Han, Fengfeng, et al.. (2022). CD39 – A bright target for cancer immunotherapy. Biomedicine & Pharmacotherapy. 151. 113066–113066. 33 indexed citations
5.
Ge, Haiyan, Wenchao Gu, Fengying Zhang, et al.. (2021). Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP. Journal of Inflammation Research. Volume 14. 3335–3348. 6 indexed citations
6.
Zhou, Jian, Jing Zhang, Jingqing Hang, et al.. (2021). The role of long-acting muscarinic antagonist/long-acting β agonist fixed-dose combination treatment for chronic obstructive pulmonary disease in China: a narrative review. Journal of Thoracic Disease. 13(11). 6453–6467. 5 indexed citations
7.
Han, Fengfeng, Chao‐Yuan Huang, Yuanyuan Zhao, et al.. (2021). Gastric cancer mesenchymal stem cells inhibitnatural killer cell function by up-regulating FBP1. Central European Journal of Immunology. 46(4). 427–437. 17 indexed citations
8.
Han, Fengfeng, et al.. (2021). Increased Serum Soluble Interleukin-2 Receptor Associated with Severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 16. 2561–2573. 8 indexed citations
9.
Ge, Haiyan, Jingqing Hang, Fengying Zhang, et al.. (2020). The Combination of Hemogram Indexes to Predict Exacerbation in Stable Chronic Obstructive Pulmonary Disease. Frontiers in Medicine. 7. 572435–572435. 24 indexed citations
10.
Xiong, Wei, He Du, Mei Xu, et al.. (2020). An authoritative algorithm most appropriate for the prediction of pulmonary embolism in patients with AECOPD. Respiratory Research. 21(1). 218–218. 3 indexed citations
11.
Gu, Wen, Xuejun Guo, Ping Yi, et al.. (2019). Detection of pulmonary ground-glass opacity based on deep learning computer artificial intelligence. BioMedical Engineering OnLine. 18(1). 6–6. 25 indexed citations
12.
Li, Xiaoming, et al.. (2019). A comparison of diagnostic consistency for asthma-chronic obstructive pulmonary disease overlap and clinical characteristics study. BMC Pulmonary Medicine. 19(1). 249–249. 1 indexed citations
13.
14.
Xu, Weiguo, Xuejun Guo, Fengfeng Han, et al.. (2017). Differences in airway remodeling and airway inflammation among moderate-severe asthma clinical phenotypes. Journal of Thoracic Disease. 9(9). 2904–2914. 15 indexed citations
15.
Ge, Xiahui, et al.. (2015). Optimal treatment for primary benign intratracheal schwannoma: A case report and review of the literature. Oncology Letters. 10(4). 2273–2276. 23 indexed citations
16.
Ge, Xiahui, Wenbin Guan, Fengfeng Han, Xuejun Guo, & Zhichao Jin. (2015). Comparison of Endobronchial Ultrasound-Guided Fine Needle Aspiration and Video-Assisted Mediastinoscopy for Mediastinal Staging of Lung Cancer. Lung. 193(5). 757–766. 40 indexed citations
17.
Song, Lin, Xiaojun Guan, Xi Chen, et al.. (2014). Mesenchymal Stem Cells Reduce Cigarette Smoke-Induced Inflammation and Airflow Obstruction in Rats via TGF-β1 Signaling. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(5). 582–590. 21 indexed citations
18.
Ge, Xiahui, et al.. (2013). Is Obstructive Sleep Apnea Associated with Cardiovascular and All-Cause Mortality?. PLoS ONE. 8(7). e69432–e69432. 84 indexed citations
19.
Guan, Xiaojun, Lin Song, Fengfeng Han, et al.. (2012). Mesenchymal stem cells protect cigarette smoke‐damaged lung and pulmonary function partly via VEGF–VEGF receptors. Journal of Cellular Biochemistry. 114(2). 323–335. 102 indexed citations
20.
Liu, Qian, Weiguo Xu, Yong Luo, et al.. (2011). Cigarette smoke‐induced skeletal muscle atrophy is associated with up‐regulation of USP‐19 via p38 and ERK MAPKs. Journal of Cellular Biochemistry. 112(9). 2307–2316. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jue Ye Breakdown of academic impact, for papers by Mary Van Demark Breakdown of academic impact, for papers by Yen‐Ta Chen Breakdown of academic impact, for papers by Bo Cui Breakdown of academic impact, for papers by Martine Lelièvre-Pégorier Breakdown of academic impact, for papers by Padmini P. S. J. Khedoe Breakdown of academic impact, for papers by Huanping Zhou Breakdown of academic impact, for papers by Aina Noguera
Rankless by CCL
2026